Drug · DIN 02423723
RAGWITEK
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since November 6, 2017; first marketed April 29, 2014.
- Drug Identification Number (DIN)
- 02423723
- Company (DIN owner)
- Alk-Abello IncPort Washington, New York, United States
- Schedule
- Schedule d; Prescription
- Dosage form
- Tablet (Orally-Disintegrating)
- Route
- Sublingual
- Therapeutic class (ATC)
- Grass pollen V01AA02
- Class
- Human
- Record last updated
- June 27, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| STANDARDIZED SHORT RAGWEED POLLEN ALLERGENIC EXTRACT | 12 UNIT |
Notices of Compliance
Health Canada approvals that name this DIN.
- May 17, 2017: NOC 19314New Drug Submission (NDS) · Transfer of drug identification number
- April 10, 2014: NOC 15500New Drug Submission (NDS)